Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Summary Background Acute promyelocytic leukaemia is a chemotherapy-sensitive subgroup of acute myeloid leukaemia characterised by the presence of the PML–RARA fusion transcript. The present standard of care, chemotherapy and all- trans retinoic acid (ATRA), results in a high proportion of patients b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet oncology 2015-10, Vol.16 (13), p.1295-1305
Hauptverfasser: Burnett, Alan K, Prof, Russell, Nigel H, Prof, Hills, Robert K, DPhil, Bowen, David, Prof, Kell, Jonathan, MD, Knapper, Steve, DM, Morgan, Yvonne G, PhD, Lok, Jennie, MSc, Grech, Angela, BA, Jones, Gail, MD, Khwaja, Asim, Prof, Friis, Lone, PhD, McMullin, Mary Frances, Prof, Hunter, Ann, MD, Clark, Richard E, Prof, Grimwade, David, Prof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!